Ström Susanne, Inzunza José, Grinnemo Karl-Henrik, Holmberg Kerstin, Matilainen Eija, Strömberg Anne-Marie, Blennow Elisabeth, Hovatta Outi
Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Hum Reprod. 2007 Dec;22(12):3051-8. doi: 10.1093/humrep/dem335. Epub 2007 Oct 24.
For clinical grade human embryonic stem cell (hESC) lines, a robust derivation system without any substances having animal origin would be required. We have gradually improved our hESC derivations. Human skin fibroblasts were used as feeder cells in derivation of all our 25 permanent fully characterized hESC lines. In the first four derivations, fetal calf serum was used as a supplement in the medium, thereafter, serum replacement medium was used. Immunosurgery generally used for isolation of the inner cell mass (ICM) still involves animal serum and complement.
We developed a practical mechanical isolation method for the ICM. Two flexible metal needles with sharpened tips, 0.125 mm in diameter, were used to open the zona pellucida and extract the ICM under a stereomicroscope. Immunohistochemical and karyotype characterization of the new hESC lines was carried out, and pluripotency was tested in vitro (immunocytochemistry and RT-PCR) and in vivo (teratoma growth).
Five hESC lines were obtained from 19 supernumerary blastocysts collected in 2005-2006 (26%), whereas in similar conditions, we obtained 16 lines from 100 blastocysts (16%) using immunosurgery in 2003-2005. The new lines had a normal karyotype and tissues originating from the three embryonic germ cell layers were present.
Mechanical isolation of the ICM proved to be an effective way to derive new hESC lines. The technique is fast, does not require any extra investment and the xeno-components of immunosurgery could be avoided.
对于临床级别的人类胚胎干细胞(hESC)系,需要一个不含有任何动物源物质的强大衍生系统。我们已逐步改进我们的hESC衍生方法。在我们所有25个经过全面表征的永久性hESC系的衍生过程中,均使用人类皮肤成纤维细胞作为饲养层细胞。在最初的四次衍生中,培养基中使用胎牛血清作为补充物,此后则使用无血清培养基。通常用于分离内细胞团(ICM)的免疫外科手术仍涉及动物血清和补体。
我们开发了一种实用的ICM机械分离方法。使用两根直径为0.125毫米、尖端磨尖的柔性金属针在体视显微镜下打开透明带并提取ICM。对新的hESC系进行免疫组织化学和核型表征,并在体外(免疫细胞化学和RT-PCR)和体内(畸胎瘤生长)测试其多能性。
从2005 - 2006年收集的19个多余囊胚中获得了5个hESC系(26%),而在类似条件下,我们在2003 - 2005年使用免疫外科手术从100个囊胚中获得了16个系(16%)。新的细胞系具有正常核型,并且存在源自三个胚胎 germ细胞层的组织。
ICM的机械分离被证明是获得新的hESC系的有效方法。该技术快速,不需要任何额外投资,并且可以避免免疫外科手术中的异种成分。